Literature DB >> 32616949

Practical Guidance in Perioperative Management of Immunosuppressive Therapy for Rheumatology Patients Undergoing Elective Surgery.

Michelle Boyce1, Anne Massicotte2.   

Abstract

Entities:  

Year:  2020        PMID: 32616949      PMCID: PMC7308162     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


× No keyword cloud information.
  6 in total

Review 1.  2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Wanruchada Katchamart; Duangkamol Aiewruengsurat; Parawee Chevaisrakul; Praveena Chiowchanwisawakit; Pornchai Dechanuwong; Punchong Hanvivadhanakul; Ajanee Mahakkanukrauh; Siriporn Manavathongchai; Chayawee Muangchan; Pongthorn Narongroeknawin; Veerapong Phumethum; Boonjing Siripaitoon; Anawat Suesuwan; Siraphop Suwannaroj; Parichat Uea-Areewongsa; Sittichai Ukritchon; Paijit Asavatanabodee; Ajchara Koolvisoot; Ratanavadee Nanagara; Kitti Totemchokchyakarn; Kanokrut Nuntirooj; Tasanee Kitumnuaypong
Journal:  Int J Rheum Dis       Date:  2017-07-21       Impact factor: 2.454

Review 2.  2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

Authors:  Susan M Goodman; Bryan Springer; Gordon Guyatt; Matthew P Abdel; Vinod Dasa; Michael George; Ora Gewurz-Singer; Jon T Giles; Beverly Johnson; Steve Lee; Lisa A Mandl; Michael A Mont; Peter Sculco; Scott Sporer; Louis Stryker; Marat Turgunbaev; Barry Brause; Antonia F Chen; Jeremy Gililland; Mark Goodman; Arlene Hurley-Rosenblatt; Kyriakos Kirou; Elena Losina; Ronald MacKenzie; Kaleb Michaud; Ted Mikuls; Linda Russell; Alexander Sah; Amy S Miller; Jasvinder A Singh; Adolph Yates
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-06-16       Impact factor: 4.794

3.  Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.

Authors:  Claire Bombardier; Glen S Hazlewood; Pooneh Akhavan; Orit Schieir; Anne Dooley; Boulos Haraoui; Majed Khraishi; Sharon A Leclercq; Jean Légaré; Dianne P Mosher; James Pencharz; Janet E Pope; John Thomson; Carter Thorne; Michel Zummer; Michael A Gardam; Johan Askling; Vivian Bykerk
Journal:  J Rheumatol       Date:  2012-06-15       Impact factor: 4.666

Review 4.  Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers.

Authors:  Peter A Rosandich; Joe T Kelley; Doyt L Conn
Journal:  Curr Opin Rheumatol       Date:  2004-05       Impact factor: 5.006

Review 5.  Perioperative management of immunosuppression in rheumatic diseases--what to do?

Authors:  Peter Härle; Rainer H Straub; Martin Fleck
Journal:  Rheumatol Int       Date:  2009-12-24       Impact factor: 2.631

Review 6.  Perioperative management of drugs commonly used in patients with rheumatic diseases: a review.

Authors:  André Silva Franco; Leandro Ryuchi Iuamoto; Rosa Maria Rodrigues Pereira
Journal:  Clinics (Sao Paulo)       Date:  2017-06       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.